Like many medicines, Cymbalta works to treat more than one condition. Cymbalta has been approved by the FDA for both the treatment of depression and the management of pain associated with diabetic peripheral neuropathy.
Cymbalta (an SSNRI) targets two chemicals, serotonin and norepinephrine, that are believed to play a role in how the brain and body affect mood and pain.
